title: [Molecular and histologic characteristics of secondary imatinib-resistant gastrointestinal stromal tumors].
authors.affiliation: tztree@126.com
authors.forename: Song
authors.initials: S
authors.lastname: Zheng
authors.forename: Jing
authors.initials: J
authors.lastname: Jia
authors.forename: Yue-long
authors.initials: YL
authors.lastname: Pan
authors.forename: De-you
authors.initials: DY
authors.lastname: Tao
authors.forename: Hong-sheng
authors.initials: HS
authors.lastname: Lu
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D019008:Drug Resistance, Neoplasm; D005091:Exons; D005743:Gastrectomy / Q000379:methods; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000601:surgery; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology* / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D010879:Piperazines / Q000627:therapeutic use*; D017354:Point Mutation; D019009:Proto-Oncogene Proteins c-kit / Q000235:genetics / Q000378:metabolism; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D019009:Proto-Oncogene Proteins c-kit